Immune-Glutamatergic Dysfunction as a Central Mechanism of the Autism Spectrum Disorders
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Despite the great number of observations being made concerning cellular and the molecular dysfunctions associated with autism spectrum disorders (ASD), the basic central mechanism of these disorders has not been proposed in the major scientific literature. Our review brings evidence that most heterogeneous symptoms of ASD have a common set of events closely connected with dysregulation of glutamatergic neurotransmission in the brain with enhancement of excitatory receptor function by pro-inflammatory immune cytokines as the underlying mechanism. We suggest that environmental and dietary excitotoxins, mercury, fluoride, and aluminum can exacerbate the pathological and clinical problems by worsening excitotoxicity and by microglial priming. In addition, each has effects on cell signaling that can affect neurodevelopment and neuronal function. Our hypothesis opens the door to a number of new treatment modes, including the nutritional factors that naturally reduce excitotoxicity and brain inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wakefield, A., Murch, S., Anthony, A., Linnell, J., Casson, D., Malik, M., Berelowitz, M., Dhillon, A., Thomson, M., Harvey, P., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11096-0 · Cited by 3,006
RetractedAutism as a strongly genetic disorder: evidence from a British twin study
Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., & Rutter, M. (1995) · Psychological Medicine · doi:10.1017/s0033291700028099 · Cited by 2,461 · cited 2×
“Studies showing higher incidence rates of 60 to 90% in monozygotic twins versus 0 to 6% in dizygotic twins suggest a herediability of over 90% [2].”
BackgroundNeuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 4×
“Activation of microglia is strongly linked to IL-1ß, which can enter the CNS following systemic immune activation, thus providing a link between vaccination and the brain inflammations [15] even though other sources of systemic immune activation may play a role.”
BackgroundInfluentialInflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
Mapping autism risk loci using genetic linkage and chromosomal rearrangements
The Autism Genome Project Consortium (2007) · Nature Genetics · doi:10.1038/ng1985 · Cited by 1,402
Autism and Abnormal Development of Brain Connectivity: Figure 1.
Belmonte, M. K., Allen, G., Beckel-Mitchener, A., Boulanger, L. M., Carper, R. A., & Webb, S. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3340-04.2004 · Cited by 1,217 · cited 1×
“While the immature brain is less susceptible to neuron death than the mature brain, seizures in the developing brain result in irreversible changes in neuronal connectivity [77].”
BackgroundTakeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., Sonobe, Y., Mizuno, T., & Suzumura, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600504200 · Cited by 749
Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD
Beattie, E. C., Carroll, R. C., Yu, X., Morishita, W., Yasuda, H., von Zastrow, M., & Malenka, R. C. (2000) · Nature Neuroscience · doi:10.1038/81823 · Cited by 745
A Genomic Screen of Autism: Evidence for a Multilocus Etiology
Risch, N., Spiker, D., Lotspeich, L., Nouri, N., Hinds, D., Hallmayer, J., Kalaydjieva, L., McCague, P., Dimiceli, S., Pitts, T., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302497 · Cited by 684 · cited 1×
“Data from whole genome screening of multiplex families (having more than one autistic child) strongly suggest that 10 or more genes interact to cause classic autism [16].”
BackgroundThe immune response in autism: a new frontier for autism research
Ashwood, P., Wills, S., & Van de Water, J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1205707 · Cited by 528 · cited 1×
“Ashwood with co-workers [81, 82] recently reviewed the immunological abnormalities reported in the ASD, which include abnormal reactivity of lymphocytes, a shift in Th1/Th2 balance, amplified release of TNF- and IL-1ß with mononuclear stimulation, presence of various anti-brain antibodies, and specific antibodies to n…”
BackgroundNeuropathological findings in autism
Palmen, S. J. M. C. (2004) · Brain · doi:10.1093/brain/awh287 · Cited by 527 · cited 2×
“…of the amygdala; hypoplasia of the inferior vermis of the cerebellum with loss of Purkinje cells, increased gliosis (GFAP) [6] [14] [15] [30] [31] Biochemical altered energy metabolism lower levels of gray matter NAA and Glx decreased protein levels of GAD higher concentration of…”
BackgroundPostmortem brain abnormalities of the glutamate neurotransmitter system in autism
Purcell, A. E., Jeon, O. H., Zimmerman, A. W., Blue, M. E., & Pevsner, J. (2001) · Neurology · doi:10.1212/wnl.57.9.1618 · Cited by 518
Fatemi, S. H., Halt, A. R., Stary, J. M., Kanodia, R., Schulz, S. C., & Realmuto, G. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01430-0 · Cited by 500
Genome-Wide Scan for Autism Susceptibility Genes
Philippe, A., Martinez, M., Guilloud-Bataille, M., Gillberg, C., Rastam, M., Sponheim, E., Coleman, M., Zappella, M., Aschauer, H., Van Maldergem, L., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.805 · Cited by 471
The impact of systemic infection on the progression of neurodegenerative disease
Perry, V. H., Newman, T. A., & Cunningham, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1032 · Cited by 428 · cited 1×
“Preexisting microglial activation has been shown to greatly magnify neurodegeneration associated with subsequent episodes of systemic immune activation; a process called microglial priming [95, 98].”
BackgroundChauhan, A., Chauhan, V., Brown, W. T., & Cohen, I. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.038 · Cited by 424
Purkinje Cell Size Is Reduced in Cerebellum of Patients with Autism
Fatemi, S. H., Halt, A. R., Realmuto, G., Earle, J., Kist, D. A., Thuras, P., & Merz, A. (2002) · Cellular and Molecular Neurobiology · doi:10.1023/a:1019861721160 · Cited by 344 · cited 1×
“A number of studies have shown that one of the most involved areas of the autistic brain is the cerebellum, particularly involving the Purkinje cells [31, 58, 59].”
BackgroundCerebrospinal Fluid and Serum Markers of Inflammation in Autism
Zimmerman, A. W., Jyonouchi, H., Comi, A. M., Connors, S. L., Milstien, S., Varsou, A., & Heyes, M. P. (2005) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2005.03.014 · Cited by 300 · cited 1×
“There is also compelling evidence that chronic activation of microglia results in a predominant neurotoxic effect on the brain, with excitotoxic levels of glutamate being secreted [90] [91].”
BackgroundNocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder
Tordjman, S., Anderson, G. M., Pichard, N., Charbuy, H., & Touitou, Y. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.003 · Cited by 296
Increased excretion of a lipid peroxidation biomarker in autism
Ming, X., Stein, T. P., Brimacombe, M., Johnson, W. G., Lambert, G. H., & Wagner, G. C. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.06.002 · Cited by 236 · cited 1×
“Significant elevations in measures of oxidative stress and LPP in autistic children were demonstrated [135, 136].”
BackgroundCirculating autoantibodies to neuronal and glial filament proteins in autism
Singh, V. K., Warren, R., Averett, R., & Ghaziuddin, M. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00045-3 · Cited by 234
Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease
Combrinck, M. I., Perry, V. H., & Cunningham, C. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00030-1 · Cited by 231 · cited 2×
“Activation of brain microglia by systemic immune stimulation can occur by way of macrophage/lymphocyte interactions at the choroid plexus and BBB interface, by IL-1ß infiltration into the brain and via the vagal and trigeminal afferents [95].”
BackgroundAshwood, P., & Wakefield, A. J. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.12.007 · Cited by 202 · cited 2×
“This allows food antigens to enter the blood stream, resulting in a high incidence of food allergy, especially to gliadin and gluten [81].”
BackgroundVojdani, A., Campbell, A. W., Anyanwu, E., Kashanian, A., Bock, K., & Vojdani, E. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00180-7 · Cited by 197
Plasma amino acid levels in children with autism and their families
Aldred, S., Moore, K. M., Fitzgerald, M., & Waring, R. H. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1022238706604 · Cited by 188 · cited 2×
“The hyperglutamatergic hypothesis of autism has been discussed recently [11, 12] focusing on findings of increased serum level of glutamate in children and adults with ASD [13, 9], the reduction of the levels of rate-limiting enzymes glutamate acid decarboxylase 65 and 67 (GAD65 and GAD67) and the increased gliosis in…”
BackgroundA preliminary trial of ascorbic acid as supplemental therapy for autism
Dolske, M. C., Spollen, J., McKay, S., Lancashire, E., & Tolbert, L. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90058-z · Cited by 168 · cited 1×
“A preliminary trial exploring the effectiveness of ascorbic acid (8g/70kg/ day) as a supplemental pharmacological treatment for autistic children reported a reduction in symptom severity [164].”
BackgroundThe development of young siblings of children with autism from 4 to 54 months
Gamliel, I., Yirmiya, N., & Sigman, M. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0341-5 · Cited by 100 · cited 1×
“Neurobehavioral and neurological loss of eye contact, deficiencies in socialization, abnormal mind function, language dysfunction, repetitive behaviors, difficulties with executive prefrontal lobe functions [1, 4, 25]”
Background
Cited by
Heavy metals: toxicity and human health effects
Jomova, K., Alomar, S. Y., Nepovimova, E., Kuca, K., & Valko, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-024-03903-2 · Cited by 983
Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?
MEYER, U., FELDON, J., & DAMMANN, O. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318212c196 · Cited by 357
Bilbo, S. D., Block, C. L., Bolton, J. L., Hanamsagar, R., & Tran, P. K. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.07.002 · Cited by 319
Microglial Dysregulation in Psychiatric Disease
Frick, L. R., Williams, K., & Pittenger, C. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/608654 · Cited by 299
“Immune-mediated dysregulation of glutamatergic neurotransmission has been proposed as a pathogenic mechanism in autism spectrum disorders more generally [99].”
BackgroundAluminum Vaccine Adjuvants: Are they Safe?
Tomljenovic, L., & A. Shaw, C. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795933740 · Cited by 211
Metadata
- Authors
- Blaylock, R., & Strunecka, A.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-01-01
- Volume
- 16
- Issue
- 2
- Pages
- 157-170
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2171114683
- Cited by
- 138
- References
- 27
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.